Sort
25,944 grants matching “neurodegeneration”
Structure, Biosynthesis & Function of Glycoproteins
$648,695Stuart A Kornfeld · Washington University · R37 · FY2018 · CA
Lentiviral Vectors for Gene Transfer
$648,642Salk Institute For Biological Studies · R01 · FY2005 · HL
Targeting proteostatic mechanisms to inhibit LRRK2-mediated neurodegeneration and neuropathology
$648,555Annie E Hiniker · University Of California, San Diego · R01 · FY2023 · NS
Deciphering the role of junctional adhesion molecule-A in neutrophil-driven inflammatory response in Alzheimer disease
$648,532Anuska V Andjelkovic-Zochowska · University Of Michigan At Ann Arbor · R01 · FY2024 · AG
Biomarker Core
$648,345Jelena Pavlovi · Albert Einstein College Of Medicine · P01 · FY2023 · AG
Air Pollution and Cognitive Function
$648,344Charles B Hall · Albert Einstein College Of Medicine · P01 · FY2023 · AG
Novel whole-genome analysis methods for Alzheimer's risk prediction
$648,343Ellen McRae Greytak · Parabon Nanolabs, Inc. · R44 · FY2024 · AG
How do microbiota determine neuronal function and protect against neurodegeneration?
$647,979Alexandra Byrne · Univ Of Massachusetts Med Sch Worcester · R56 · FY2024 · AG
Epigenetic Regulation of Nuclear cGAS Activity in Aging-Related Inflammation
$647,866Qi Zhang · Univ Of North Carolina Chapel Hill · R01 · FY2025 · AG
Amyloids in Enamel Development
$647,832Stefan Friedrich Habelitz · University Of California, San Francisco · R01 · FY2019 · DE
Enhancement of Brain Dysfunction in Sepsis Survivors by Alzheimerâs Disease Neuropathology
$647,803Benjamin Herschel Singer · University Of Michigan At Ann Arbor · R01 · FY2022 · AG
Amyloids in Enamel Development
$647,566Stefan Friedrich Habelitz · University Of California, San Francisco · R01 · FY2017 · DE
Treating with Gamma-Secretase Modulators to Prevent Neurodegeneration in Mouse Models of Down Syndrome and Alzheimer Disease
$647,470William C Mobley · University Of California, San Diego · R01 · FY2020 · AG
Human hippocampal contributions to rapid encoding-retrieval interactions during memory formation
$647,452Joel L Voss · University Of Chicago · R01 · FY2024 · MH
ProSAAS-mediated neuroprotective mechanisms in Alzheimer's and Parkinson's diseases: the role of secretory chaperones in neurodegeneration
$647,287Iris Lindberg · University Of Maryland Baltimore · R01 · FY2019 · AG
Using CRISPR technology to study the function of paralogous genes
$647,246Norbert Perrimon · Harvard Medical School · R24 · FY2018 · OD
Formation of Tau RNA Complexes disrupts tau function and drives tau neuropathology
$647,228Brian C. Kraemer · Seattle Inst For Biomedical/Clinical Res · R01 · FY2024 · AG
Characterization and targeting of a novel pathway promoting Parkinsonâs Disease
$647,116Daniel A Lawrence · University Of Michigan At Ann Arbor · R56 · FY2023 · NS
Probing the role of SORL1 and endosomal network genetic variation on Alzheimer's disease phenotypes in human neurons.
$647,038Jessica Elaine Young · University Of Washington · R01 · FY2021 · AG
Probing the role of SORL1 and endosomal network genetic variation on Alzheimer's disease phenotypes in human neurons.
$647,038Jessica Elaine Young · University Of Washington · R01 · FY2020 · AG
Probing the role of SORL1 and endosomal network genetic variation on Alzheimer's disease phenotypes in human neurons.
$647,038Jessica Elaine Young · University Of Washington · R01 · FY2022 · AG
Defining Pathogenic Mechanisms and Therapeutic Opportunities for Langerhans Cell Histiocytosis
$646,985Miriam Merad · Icahn School Of Medicine At Mount Sinai · R01 · FY2025 · CA
Advanced glycation endproducts (AGEs) as metabolic by-products that mediate neurodegeneration.
$646,911Pankaj Kapahi · Buck Institute For Research On Aging · R01 · FY2020 · AG
Advanced glycation endproducts (AGEs) as metabolic by-products that mediate neurodegeneration.
$646,911Pankaj Kapahi · Buck Institute For Research On Aging · R01 · FY2021 · AG
Advanced glycation endproducts (AGEs) as metabolic by-products that mediate neurodegeneration.
$646,911Pankaj Kapahi · Buck Institute For Research On Aging · R01 · FY2023 · AG